Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | INCY | BMY | AMGN | GILD | REGN |
Company | Incyte Corp | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 50.99 | 44.68 | 265.72 | 65.50 | 881.72 |
High | 51.79 | 45.37 | 271.68 | 66.35 | 887.48 |
Low | 50.87 | 44.34 | 265.72 | 64.63 | 875.23 |
Last | 51.64 | 45.20 | 270.00 | 65.75 | 880.00 |
Change | +0.46 | +0.50 | +0.62 | +0.48 | -10.68 |
% Change | +0.90% | +1.12% | +0.23% | +0.74% | -1.20% |
Volume | 429,477 | 6,781,285 | 429,418 | 5,419,037 | 164,605 |
20-Day Average Volume | 1,628,879 | 12,464,783 | 2,055,718 | 6,707,440 | 439,733 |
Previous Close | 51.18 | 44.70 | 269.38 | 65.27 | 890.68 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 53.74 | 49.49 | 269.99 | 68.31 | 918.54 |
20-Day Raw Stochastic | 18.75% | 8.95% | 40.77% | 13.04% | 8.30% |
20-Day Relative Strength | 30.39% | 31.16% | 45.65% | 31.11% | 33.07% |
Weighted Alpha | -29.54 | -33.65 | +9.55 | -22.95 | +9.80 |
Today's Opinion | 100% Sell | 88% Sell | 56% Sell | 100% Sell | 8% Sell |
Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
Last Month's Opinion | 72% Sell | 8% Buy | 40% Buy | 88% Sell | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | -1.38% since 04/19/24 | -7.57% since 04/19/24 | +0.45% since 04/19/24 | -1.51% since 04/19/24 | -1.53% since 04/19/24 |
Low | 50.35 on 04/25/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
High | 52.62 on 04/22/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 915.70 on 04/24/24 |
1-Month | |||||
%Chg | -8.71% since 03/26/24 | -13.94% since 03/26/24 | -4.12% since 03/26/24 | -9.20% since 03/26/24 | -8.35% since 03/26/24 |
Low | 50.35 on 04/25/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
High | 57.40 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
3-Month | |||||
%Chg | -14.87% since 01/26/24 | -9.00% since 01/26/24 | -13.35% since 01/26/24 | -17.32% since 01/26/24 | -6.06% since 01/26/24 |
Low | 50.35 on 04/25/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
High | 61.87 on 02/23/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -4.87% since 10/26/23 | -14.62% since 10/26/23 | +0.16% since 10/26/23 | -16.24% since 10/26/23 | +11.50% since 10/26/23 |
Low | 50.27 on 10/31/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 769.19 on 10/27/23 |
High | 67.36 on 01/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 11,491,241 | 90,596,128 | 144,488,960 | 81,266,176 | 97,762,816 |
Shares Outstanding, K | 224,526 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
Annual Sales | 3,695,650,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
Annual Net Income | 597,600,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
Last Quarter Sales | 1,013,340,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
Last Quarter Net Income | 201,080,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
60-Month Beta | 0.65 | 0.39 | 0.58 | 0.19 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | 1.06 on 02/13/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 04/30/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 19.31 | 6.51 | 14.64 | 9.98 | 24.12 |